Emerging Targeted Agents in AML

preview_player
Показать описание
Richard M. Stone, MD, and Hervé Dombret, MD, share their insights on the emerging agents for the treatment of acute myeloid leukemia, including FLT3 inhibitors and other potential targeted therapies.
Рекомендации по теме